H71.33
Diffuse cholesteatosis, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse cholesteatosis, bilateral, is a condition affecting the middle ear, characterized by the abnormal accumulation of keratinizing squamous epithelium in both ears. This buildup can lead to hearing difficulties and other ear-related problems. Often associated with chronic ear issues, this condition requires proper diagnosis and management to prevent potential complications. It is identified under the ICD-10 code H71.33, which helps healthcare providers document and classify this specific diagnosis.
Causes & Symptoms
Clinical Causes: Chronic otitis media (long-term middle ear infections) Eustachian tube dysfunction Recurrent middle ear infections leading to epithelial changes Previous ear surgeries or trauma Genetic predisposition affecting ear tissue health
Key Symptoms: Gradual hearing loss in both ears ear fullness or pressure sensation Recurrent ear infections or otorrhea (ear discharge) Discomfort or dull ache in the ears Possible tinnitus (ringing in the ears)
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive ear examination by an otolaryngologist, including otoscopy to observe the eardrum and middle ear. Hearing tests (audiometry) can assess the extent of hearing impairment. Imaging techniques such as computed tomography (CT) scans may be used to evaluate the extent of cholesteatoma and middle ear structures. Identifying characteristic tissue buildup and ruling out other ear pathologies are key components of the diagnostic process.
Treatment Protocols: Management of diffuse cholesteatosis involves surgical intervention in most cases. The primary goals are to remove the abnormal epithelial tissue, prevent further damage, and improve hearing. Common procedures include cholesteatoma removal via mastoidectomy or tympanoplasty. Postoperative care may involve antibiotics to control infection and regular follow-up to monitor for recurrence. In some cases, hearing aids or assistive listening devices may be recommended to compensate for hearing loss. Preventative measures focus on controlling ear infections and maintaining ear health.
Clinical Advice & FAQs
Billing Guidance
Is H71.33 a billable ICD-10 code?
Yes, H71.33 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H71.33?
Clinical documentation must specify the nature of Diffuse cholesteatosis, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference